Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $392.0500 (-2.73%) ($387.8350 - $401.4300) on Thu. Oct. 4, 2018. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.68% (three month average) | | RSI | 51 | | Latest Price | $392.0500(-2.73%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.7% a day on average for past five trading days. | | Weekly Trend | REGN advances 1.4% a week on average for past two weeks. | | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | | Factors Impacting REGN price | REGN will decline at least -0.84% in a week (0% probabilities).
VXX(-12%) UUP(-11%) TLT(-7%) VIXM(-4%) IFRA(-3%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.84% (StdDev 1.68%) | | Hourly BBV | 0 () | | Intraday Trend | -2.3% | | | | | |
|
| Resistance Level | $393.68 | | 5 Day Moving Average | $398.79(-1.69%) | | 10 Day Moving Average | $396.38(-1.09%) | | 20 Day Moving Average | $393.68(-0.41%) | | To recent high | -4% | | To recent low | 8.6% | | Market Cap | $41.569b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |